UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 1934 For the quarterly period ended: January 31, Commission File Number: HARTFORD GREAT HEALTH CORP. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation or organization) 51-0675116 (I.R.S. Employer Identification Number) 8832 Glendon Way, Rosemead, California91770 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number including area code: Former name, former address, and former fiscal year, if changed since last report Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐ Indicate by check mark whether the registrant has submitted electronically, Indicate by checkmark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes Securities registered pursuant to Section 12(b) of the Act: State the number of shares outstanding of each of the (Mark One)☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19342018☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from ________ to ________ For the transition period from ____ to ________333-164633PHOTOAMIGO, INC.NEVADA20-5422795(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number)2532 Foothill Road, Santa Barbara, CA. 93105Registrant's(805) 272-0874and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files)."large“large accelerated filer," "accelerated filer"” “accelerated filer” and "smaller“smaller reporting company"company” in Rule 12b-2 of the Exchange Act.Large accelerated filer ☐ Accelerated filer ☐Non-accelerated filer ☐ Smaller reporting company ☒Emerging growth company ☐Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☒ Emerging growth company ☒ x ☐ No ☐Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.001 par value HFUS OTC Markets Group issuer'sissuer’s classes of common equity, as of the latest practicable date: 3,018,000 shares of common stock outstanding as of March 13, 2018.
| 2 |
HARTFORD GREAT HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
| January 31, 2018 | July 31, 2017 | |||||||
| (unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 1,117 | $ | 1,928 | ||||
| Total current assets | 1,117 | 1,928 | ||||||
| Fixed Assets | ||||||||
| Computer equipment | 2,792 | 2,792 | ||||||
| Accumulated depreciation | (2,732 | ) | (2,262 | ) | ||||
| Net book value | 60 | 530 | ||||||
| Total assets | $ | 1,177 | $ | 2,458 | ||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 1,810 | $ | 2,191 | ||||
| Accrued Interest | 494 | 237 | ||||||
| Advances from shareholders | 33,843 | 21,180 | ||||||
| Total current liabilities | 36,147 | 23,608 | ||||||
| Total liabilities | 36,147 | 23,608 | ||||||
| Commitments and contingencies (Notes 2 and 4) | ||||||||
| Stockholders' deficit: | ||||||||
| Preferred stock - $0.001 par value, 5,000,000 shares authorized: | ||||||||
| No shares issued or outstanding | - | - | ||||||
| Common stock - $0.001 par value, 100,000,000 shares authorized: | ||||||||
| 3,018,000 shares issued and outstanding | 3,018 | 3,018 | ||||||
| Additional paid-in capital | 283,113 | 283,113 | ||||||
| Accumulated (Deficit) | (321,101 | ) | (307,281 | ) | ||||
| Total stockholders' deficit | (34,970 | ) | (21,150 | ) | ||||
| Total liabilities and stockholders' deficit | $ | 1,177 | $ | 2,458 | ||||
| January 31, 2024 | July 31, 2023 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 8,484 | $ | 5,793 | ||||
| Prepaid and Other current receivables | 282 | 280 | ||||||
| Related party receivable | 964 | 964 | ||||||
| Total Current Assets | 9,730 | 7,037 | ||||||
| Non-current Assets | ||||||||
| Property and equipment, net | 597 | 730 | ||||||
| Total Non-current Assets | 597 | 730 | ||||||
| TOTAL ASSETS | $ | 10,327 | $ | 7,767 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current Liabilities | ||||||||
| Related party loan and payables | $ | 4,440,337 | $ | 4,367,194 | ||||
| Other current payable | 131,835 | 130,279 | ||||||
| Total Current Liabilities | 4,572,172 | 4,497,473 | ||||||
| TOTAL LIABILITIES | 4,572,172 | 4,497,473 | ||||||
| Commitments and contingencies | - | - | ||||||
| Stockholders’ Equity (Deficit) | ||||||||
| Preferred stock - $ par value, shares authorized, shares issued and outstanding | - | - | ||||||
| Common stock - $ par value, shares authorized, shares outstanding at both of January 31, 2024 and July 31, 2023. | 100,108 | 100,108 | ||||||
| Additional paid-in capital | 2,173,521 | 2,173,521 | ||||||
| Accumulated deficit | (7,049,170 | ) | (7,003,717 | ) | ||||
| Accumulated other comprehensive income | 213,696 | 240,382 | ||||||
| Total Stockholders’ Deficit | (4,561,845 | ) | (4,489,706 | ) | ||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ | 10,327 | $ | 7,767 | ||||
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
| 3 |
HARTFORD GREAT HEALTH CORP.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months | Three Months | Six Months | Six Months | |||||||||||||
| ended | ended | ended | ended | |||||||||||||
| January 31, 2018 | January 31, 2017 | January 31, 2018 | January 31, 2017 | |||||||||||||
| Revenues | $ | - | $ | - | $ | - | $ | - | ||||||||
| Operating expenses: | ||||||||||||||||
| Website development | 2,448 | 589 | 2,625 | 766 | ||||||||||||
| Legal and accounting fees | 7,450 | 4,500 | 8,237 | 5,175 | ||||||||||||
| Investor relations | 1,751 | 1,950 | 2,051 | 2,908 | ||||||||||||
| Other general and administrative | 103 | 3 | 180 | 34 | ||||||||||||
| Depreciation Expense | 235 | 235 | 470 | 470 | ||||||||||||
| Total operating expenses | 11,987 | 7,277 | 13,563 | 9,353 | ||||||||||||
| Operating (loss) | (11,987 | ) | (7,277 | ) | (13,563 | ) | (9,353 | ) | ||||||||
| Other income(expense): | ||||||||||||||||
| Interest expense | (150 | ) | (45 | ) | (257 | ) | (59 | ) | ||||||||
| Other income (expense) net | (150 | ) | (45 | ) | (257 | ) | (59 | ) | ||||||||
| Net (loss) | $ | (12,137 | ) | $ | (7,322 | ) | $ | (13,820 | ) | $ | (9,412 | ) | ||||
| Net (loss) per common share: | ||||||||||||||||
| Basic and Diluted * | $ | - | $ | - | $ | - | $ | - | ||||||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic and Diluted | 3,018,000 | 3,018,000 | 3,018,000 | 3,018,000 | ||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| January 31, | January 31, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Revenue - Related Party | $ | 62,443 | $ | - | $ | 62,443 | $ | - | ||||||||
| Cost of revenue - Related Party | 55,505 | - | 55,505 | - | ||||||||||||
| Gross Profit | 6,938 | - | 6,938 | - | ||||||||||||
| Operating expenses | ||||||||||||||||
| Selling, general and administrative | 21,942 | 21,362 | 42,134 | 76,010 | ||||||||||||
| Total operating expenses | 21,942 | 21,362 | 42,134 | 76,010 | ||||||||||||
| Operating Loss | (15,004 | ) | (21,362 | ) | (35,196 | ) | (76,010 | ) | ||||||||
| Other Income (Expense) | ||||||||||||||||
| Interest (expense), net | (5,067 | ) | (4,089 | ) | (10,331 | ) | (8,178 | ) | ||||||||
| Gain on disposal of subsidiary | - | - | - | 539,230 | ||||||||||||
| Other income (expense), net | 74 | - | 74 | (91 | ) | |||||||||||
| Other income (expense), net | (4,993 | ) | (4,089 | ) | (10,257 | ) | 530,961 | |||||||||
| (Loss) income before income taxes | (19,997 | ) | (25,451 | ) | (45,453 | ) | 454,951 | |||||||||
| Income Tax Expense | - | - | - | - | ||||||||||||
| Net (loss) income | (19,997 | ) | (25,451 | ) | (45,453 | ) | 454,951 | |||||||||
| Net (loss) income per common share: | ||||||||||||||||
| Basic and diluted | $ | ) | $ | ) | $ | ) | $ | |||||||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic and diluted | ||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
| 4 |
HARTFORD GREAT HEALTH CORP.
CONDENSED STATEMENTCONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
| Additional | Total | |||||||||||||||||||
| Common Stock | Paid - in | Accumulated | Stockholders' | |||||||||||||||||
| Shares | Amount | Capital | (Deficit) | Equity (Deficit) | ||||||||||||||||
| Balance, July 31 , 2017 | 3,018,000 | 3,018 | 283,113 | (307,281 | ) | (21,150 | ) | |||||||||||||
| Net (loss) for the period | - | - | - | (13,820 | ) | (13,820 | ) | |||||||||||||
| Balance, January 31 , 2018 | 3,018,000 | 3,018 | $ | 283,113 | $ | (321,101 | ) | $ | (34,970 | ) | ||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Three months ended | Six months ended | |||||||||||||||
| January 31, | January 31, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| Net (loss) income | $ | (19,997 | ) | $ | (25,451 | ) | $ | (45,453 | ) | $ | 454,951 | |||||
| Other Comprehensive (loss) income, net of income tax | ||||||||||||||||
| Foreign currency translation adjustments | (123,853 | ) | (322,644 | ) | (26,686 | ) | 23,289 | |||||||||
| Total other comprehensive (loss) income | (123,853 | ) | (322,644 | ) | (26,686 | ) | 23,289 | |||||||||
| Total Comprehensive (loss) income | $ | (143,850 | ) | $ | (348,095 | ) | $ | (72,139 | ) | $ | 478,240 | |||||
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
| 5 |
HARTFORD GREAT HEALTH CORP.
CONDENSED STATEMENTSCONSOLIDATED STATEMENT OF CASH FLOWS
| Six Months | Six Months | |||||||
| ended | ended | |||||||
| January 31, 2018 | January 31, 2017 | |||||||
| Cash flows from operating activities: | ||||||||
| Net (loss) | $ | (13,820 | ) | $ | (9,412 | ) | ||
| Adjustments to reconcile net (loss) to net cash | ||||||||
| used by operating activities: | ||||||||
| Depreciation | 470 | 470 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Increase/(decrease) in accounts payable | (381 | ) | 42 | |||||
| Increase/(decrease) in interest payable | 257 | 59 | ||||||
| Net cash (used in) operating activities | (13,474 | ) | (8,841 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Net cash (used in) investing activities | 0 | 0 | ||||||
| Cash flows from financing activities: | ||||||||
| Loans from shareholders | 12,663 | 9,980 | ||||||
| Net cash provided by financing activities | 12,663 | 9,980 | ||||||
| Net increase (decrease) in cash and equivalents | (811 | ) | 1,139 | |||||
| Cash and equivalents at beginning of period | 1,928 | 359 | ||||||
| Cash and equivalents at end of period | $ | 1,117 | $ | 1,498 | ||||
| Supplemental Cash Flow Information | ||||||||
| Interest paid | $ | - | $ | - | ||||
| Income taxes paid | $ | - | $ | - | ||||
| Accumulated | Total | |||||||||||||||||||||||
| Additional | Other | Stockholders’ | ||||||||||||||||||||||
| Common Stock | Paid - in | Accumulated | Comprehensive | Equity | ||||||||||||||||||||
| Shares | Amount | Capital | (Deficit) | income | (Deficit) | |||||||||||||||||||
| Balance, July 31, 2023 | 100,108,000 | 100,108 | 2,173,521 | (7,003,717 | ) | 240,382 | - | (4,489,706 | ) | |||||||||||||||
| Net loss | - | - | - | (25,456 | ) | - | - | (25,456 | ) | |||||||||||||||
| Foreign currency translation adjustment | - | - | - | - | 97,167 | - | 97,167 | |||||||||||||||||
| Balance, October 31, 2023 (unaudited) | 100,108,000 | 100,108 | 2,173,521 | (7,029,173 | ) | 337,549 | - | (4,417,995 | ) | |||||||||||||||
| Net loss | - | - | - | (19,997 | ) | - | - | (19,997 | ) | |||||||||||||||
| Foreign currency translation adjustment | - | - | - | - | (123,853 | ) | (123,853 | ) | ||||||||||||||||
| Balance, January 31, 2024 (unaudited) | 100,108,000 | 100,108 | 2,173,521 | (7,049,170 | ) | 213,696 | - | (4,561,845 | ) | |||||||||||||||
| Accumulated | Total | |||||||||||||||||||||||||||
| Additional | Other | Stockholders’ | ||||||||||||||||||||||||||
| Common Stock | Paid - in | Accumulated | Comprehensive | Noncontrolling | Equity | |||||||||||||||||||||||
| Shares | Amount | Capital | (Deficit) | (loss) income | Interest | (Deficit) | ||||||||||||||||||||||
| Balance, July 31, 2022 | 100,108,000 | 100,108 | 2,173,521 | (7,400,620 | ) | (16,742 | ) | (1,288,916 | ) | (6,432,649 | ) | |||||||||||||||||
| Balance, | 100,108,000 | 100,108 | 2,173,521 | (7,400,620 | ) | (16,742 | ) | (1,288,916 | ) | (6,432,649 | ) | |||||||||||||||||
| Net income | - | - | - | 480,402 | 480,402 | |||||||||||||||||||||||
| Disposal of subsidiary | 1,307,586 | 1,307,586 | ||||||||||||||||||||||||||
| Foreign currency translation adjustment | 345,933 | (18,670 | ) | 327,263 | ||||||||||||||||||||||||
| Balance, October 31, 2022 (unaudited) | 100,108,000 | 100,108 | 2,173,521 | (6,920,218 | ) | 329,191 | - | (4,317,398 | ) | |||||||||||||||||||
| Net income | - | - | - | (25,451 | ) | - | - | (25,451 | ) | |||||||||||||||||||
| Net income (loss) | - | - | - | (25,451 | ) | - | - | (25,451 | ) | |||||||||||||||||||
| Foreign currency translation adjustment | - | - | - | - | (322,644 | ) | - | (322,644 | ) | |||||||||||||||||||
| Balance, January 31, 2023 (unaudited) | 100,108,000 | 100,108 | 2,173,521 | (6,945,669 | ) | 6,547 | - | (4,665,493 | ) | |||||||||||||||||||
| Balance, | 100,108,000 | 100,108 | 2,173,521 | (6,945,669 | ) | 6,547 | - | (4,665,493 | ) | |||||||||||||||||||
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
| 6 |
HARTFORD GREAT HEALTH CORP.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| 2024 | 2023 | |||||||
| Six months ended | ||||||||
| January 31, | ||||||||
| 2024 | 2023 | |||||||
| Cash flows from operating activities: | ||||||||
| Net (loss) income | $ | (45,453 | ) | $ | 454,951 | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
| Depreciation | 136 | - | ||||||
| Disposal of subsidiaries | - | (539,230 | ) | |||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid and Other current receivables | - | 827 | ||||||
| Related party receivables and payables | 10,330 | 26,955 | ||||||
| Other current payable | 694 | (6,631 | ) | |||||
| Net cash used in operating activities | (34,293 | ) | (63,128 | ) | ||||
| Cash flows from investing activities: | ||||||||
| Net cash used in investing activities | - | - | ||||||
| Cash flows from financing activities: | ||||||||
| Proceeds of related party notes payable | 36,000 | 60,000 | ||||||
| Advances from related parties | 971 | - | ||||||
| Net cash provided by financing activities | 36,971 | 60,000 | ||||||
| Effect of exchange rate changes on cash | 13 | (1,524 | ) | |||||
| Net change in Cash, cash equivalents and restricted cash | 2,691 | (4,652 | ) | |||||
| Cash, cash equivalents and restricted cash at beginning of period | 5,793 | 15,227 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 8,484 | $ | 10,575 | ||||
| Supplemental Cash Flow Information | ||||||||
| Interest paid | $ | - | $ | - | ||||
| Income taxes paid | $ | - | $ | - | ||||
The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.
| 7 |
HARTFORD GREAT HEALTH CORP.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
This summary of significant accounting policies is presented to assist in understanding the six month periods ended January 31, 2018Company’s financial statements. The financial statements and 2017
Organization
Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008 under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018 and since then we have been engaged in activities to formulate and implement our business plans.
Through its wholly owned subsidiary - Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF) and HZHF’s 60 percent owned subsidiary - Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”), and through Shanghai Hartford Health Management, Ltd. (“HFSH”) and its 90 percent owned subsidiary - Shanghai Qiao Garden International Travel Agency (“Qiao Garden Int’l Travel”), the Company engages in hospitality industry in China. Qiao Garden Int’l Travel was disposed on December 31, 2020.
The Company started to engage in early childhood education industry at Hartford International Education Technology Co., Ltd (“HF Int’l Education”). On July 24, 2019 and March 23, 2020, HF Int’l Education established two 100% owned subsidiaries, Pudong Haojin Childhood Education Ltd. (“PDHJ”) and Shanghai Hongkou HaiDeFuDe Childcare Co., Ltd.(“HDFD”), respectively, to operate the early childhood education service under the brand name of “HaiDeFuDe” in Shanghai, China. On July 20, 2020, HF Int’l Education entered an agreement with two individuals to acquire the whole ownership of Shanghai Gelinke Childcare Education Center (“Gelinke”). Gelinke temporally ceased its operations by the end of August 2021. On August 31, 2021, PDHJ established one 96% owned subsidiary, Shanghai HDFD Zhongli Education Technology Co., Ltd. (“Zhongli”), two individual investors hold the remaining 4% ownership.
Impacted by the government regulation implemented in education industry and the notes thereto includedrestrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500). See Note 3 Acquisitions and Disposals.
On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. HFZY mainly engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.
Basis of Presentation
The consolidated financial statements include the accounts of Hartford Great Health Corp, its wholly-owned subsidiaries and subsidiaries in which it has a controlling interest. The Company reports noncontrolling interests of the consolidated entities as a component of equity separate from the Company’s equity. All material inter-company transactions between and among the Company and its consolidated subsidiaries have been eliminated in the Company's Form 10-K.
Use of Estimates:
The preparation of financial statements in conformity with US GAAP requires the Company'sCompany’s management to make estimates and assumptions that affect the amounts of assets and liabilities, the identification and disclosure of impaired assets and contingent liabilities at the date of the financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
| 8 |
Income Taxes:
The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Accounting for Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards.carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized.
The Tax Reform Act permanently reduces the U.S. corporate income tax rate to a flat 21% rate, effective January 1, 2018. In addition, the 2017 Tax Act also creates a new requirement that certain income (i.e., Global Intangible Low-Taxed Income (“GILTI”)) earned by controlled foreign corporations (“CFCs”) must be included in the gross income of the CFCs’ U.S. shareholder income. The tax law in PRC applies an income tax rate of 25% to all enterprises. The Company’s subsidiary does not receive any preferential tax treatment from local government. The Company has been in loss position for years and zero amount of tax provisions, including GILTI. Deferred tax assets as of the reporting periods ended were fully reserved for valuation allowance as they are more likely than not to be realized.
Revenue Recognition:
The Company follows the five steps approach for revenue recognition under Topic 606: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. Billings to customers for which services are not commenced operations,rendered are considered deferred revenue. The Company’s revenue is recognized when it satisfies a single performance obligation by transferring control of its products or providing services to a customer. The Company’s general payment terms are short-term in its development stage,duration. The Company does not have significant financing components or payment terms.
The Company is developing business plan to provide customers with vertical integration services from early-stage advertising video creativity, shooting, editing, to advertising operation and has not yetmanagement on social media apps. Most of the advertising revenue will be generated anyby placing ad products on Tik Tok, Toutiao, Kwai, RED, WeChat, and other third-party affiliated websites and mobile applications. The revenues from operations. Revenues are expected tothe display of impression-based ads will be derived principally from subscriptions to our website.
In the past years, the company’s main operations were issued or outstanding duringfocusing on Early childhood education services and Hospitality services. Impacted by the Covid-19 pandemic and Chinese regulation on education industry, both early childhood education services and hospitality services have been sold on August 1 2022. Thus, there was no revenue recognized for the three and six month periodsmonths ended January 31, 2018 or 2017.
Recent Accounting Pronouncements:
Recently not yet adopted accounting pronouncements
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740), Improvements to Income Tax Disclosures. The new guidance requires enhanced disclosures about income tax expenses. The Company has reviewed allis required to adopt this guidance in the first quarter of the fiscal year 2026. Early adoption is permitted on a prospective basis. We are currently evaluating the impact of this ASU on our annual income tax disclosures.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280), Improvements to Reportable Segment Disclosures. The new guidance requires enhanced disclosures about significant segment expenses. The Company is required to adopt this guidance for its annual reporting in fiscal year 2025 and for interim period reporting beginning the first quarter of fiscal year 2026 on a retrospective basis. Early adoption is permitted. We are currently evaluating the impact of this ASU on our segment disclosures.
The Company does not believe other recently issued but not yet effective accounting pronouncements and does not believe any of these pronouncements willstandards, if currently adopted, would have a material impacteffect on the Company.
NOTE 2. GOING CONCERN
The accompanying financial statements were prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal course of business. However, PhotoAmigoHartford Great Health Corp. has incurred losses since inception, (April 2, 2008), resulting in an accumulated deficit of $321,101$7,049,170 as of January 31, 2018. These conditions raise2024. This condition raises substantial doubt about the ability of PhotoAmigoHartford Great Health Corp. to continue as a going concern.
In view of these matters, continuation as a going concern is dependent upon several factors, including the availability of debt or equity funding upon terms and conditions acceptable to PhotoAmigo,Hartford Great Health Corp., and ultimately achieving profitable operations. Management believes that Hartford Great Health Corp.’s business plan provides it with an opportunity to continue as a going concern. However, management cannot provide assurance that PhotoAmigoHartford Great Health Corp. will meet its objectives and be able to continue in operation.
The financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of PhotoAmigoHartford Great Health Corp. to continue as a going concern.
NOTE 3. ACQUISITIONS AND DISPOSALS
In January 2019, HFSH entered agreements to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). On August 1, 2022, HFSH decided to withdraw from the agreement entered in January 2019 to acquire 100 percent equity interest of Shanghai Luo Sheng International Trade Ltd. (“SH Luosheng”). There was no penalty levied or to be levied due to delayed execution or inexecution.
Impacted by the government regulation newly implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, the Company’s business hasn’t been developed as planned and occurred significant loss from the early child education practice. To avoid further operation losses, subsequently on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell 90 percent ownership of HF Int’l Education and its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell 100 percent ownership of HZHF and its subsidiaries for $1,000 (RMB 6,500).
SCHEDULE OF NET ASSETS (LIABILITIES) DISPOSED OF SUBSIDIARY
| Net assets (liabilities) disposed of: | ||||
| Cash and cash equivalents | $ | 4,938 | ||
| Prepaid and Other current receivables | 45,532 | |||
| Related party receivable | 428,519 | |||
| Inventory | 305,124 | |||
| Property and equipment - Net | 582,707 | |||
| ROU assets-Operating lease | 2,836,698 | |||
| Other assets | 296,218 | |||
| Related party loan and payables | (1,321,549 | ) | ||
| Contract liabilities | (547,906 | ) | ||
| Lease liabilities, current and noncurrent | (3,715,688 | ) | ||
| Other current payable | (401,782 | ) | ||
| Other liabilities | (357,796 | ) | ||
| Noncontrolling interest | 1,307,586 | |||
| Net assets (liabilities) of the subsidiaries, excluding noncontrolling interest | (537,399 | ) | ||
| Consideration | 1,831 | |||
| Gain on disposal of the subsidiaries | $ | (539,230 | ) | |
NOTE 4. RELATED PARTY TRANSACTIONS
Related Party Receivables
HFUS had $964 related party receivable as of both January 31, 2024 and July 31, 2023, due from SH Oversea in relation to the disposal consideration.
Related Party Payables and loans
As of January 31, 2024 and July 31, 2023, amounts of $582,601 and $586,236, respectively, are payable to SH Qiaohong. The balances were mainly funding support from SH Qiaohong for operation. The funding support bears no interest and due on demand.
HFSH had payable balances to Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), an entity previously was managed by the same management team, in the amounts of $3,321,300 and $3,291,324 as of January 31, 2024 and July 31, 2023, respectively. The payable is funding support from SH Oversea for operation, bears no interest and due on demand.
HFUS borrowed in form of a short-term loan at 5% per annum from a related party, Hartford Hotel Investment Inc., an entity managed by the same management team. $5,067 and $10,331 of interest expenses were recorded during the three and six months ended January 31, 2018,2024, respectively. $4,089 and $8,178 of interest expenses were recorded during the Company borrowed $12,663 from four shareholders to fund the Company's ongoing activities. The shareholders have not received any equity for these loansthree and these loans are repayable by the Company. Simple interest accrues on these notes at 2% annually. Principle and interest are due upon sale or merger of the company or upon demand. The Company has accrued an interest expense of $257 for the six months ended January 31, 20182023, respectively. As of January 31, 2024 and July 31, 2023, the unpaid principal and interest amount of $463,831 and $417,501, respectively, will be due on demand.
The remaining related party payable of $72,605 and $72,133 as of January 31, 2024 and July 31, 2023, respectively, represents the unpaid portion of operating advances made to the Company by its main shareholder, Mr. Lianyue Song. These advances do not bear interest and are considered due on demand.
Other Related Party Transactions
During the three and six months ended January 31, 2024, the Company generated $62,443 revenue from designing, making, and placing video advertising for its related parties, primarily Shanghai DuBian Assets Management Ltd., which is managed by the Company’s major shareholder’s relatives. For the three and six months ended January 31, 2024, the Company incurred $55,505 in costs related to these notes. This compares to the $9,980 borrowedrevenue generation, primarily stemming from four shareholders: $2,500 from three and $2,480 fromservices provided by another related party, HF Int’l Education, a fourth shareholder during the first six monthssubsidiary of 2017. During the same timeframe in 2017 the Company accrued an interest expense of $59 for the six months.
Office space at Rosemead, CA is provided to PhotoAmigoHartford Great Health Corp. at no additional cost by the sole executive officer. No provision for these costs has been included in these financial statements as the amounts are not material.
| Period Ending | Estimated NOL carry-forward | NOL expires | Estimated tax benefit from NOL | Valuation allowance | Change in valuation allowance | Net tax asset | ||||||||||||||||||
| July 31, 2008 | $ | 86,500 | 2028 | $ | 12,900 | $ | (12,900 | ) | $ | (12,900 | ) | $ | - | |||||||||||
| July 31, 2009 | $ | 122,700 | 2029 | $ | 18,400 | $ | (18,400 | ) | $ | (5,500 | ) | $ | - | |||||||||||
| July 31, 2010 | $ | 147,700 | 2030 | $ | 22,100 | $ | (22,100 | ) | $ | (3,700 | ) | $ | - | |||||||||||
| July 31, 2011 | $ | 178,100 | 2031 | $ | 26,700 | $ | (26,700 | ) | $ | (4,600 | ) | $ | - | |||||||||||
| July 31, 2012 | $ | 200,100 | 2032 | $ | 30,000 | $ | (30,000 | ) | $ | (3,300 | ) | $ | - | |||||||||||
| July 31, 2013 | $ | 217,100 | 2033 | $ | 32,500 | $ | (32,500 | ) | $ | (2,500 | ) | $ | - | |||||||||||
| July 31, 2014 | $ | 238,100 | 2034 | $ | 35,700 | $ | (35,700 | ) | $ | (3,200 | ) | $ | - | |||||||||||
| July 31, 2015 | $ | 259,100 | 2035 | $ | 38,800 | $ | ( 38,800 | ) | $ | ( 3,100 | ) | $ | - | |||||||||||
| July 31, 2016 | $ | 287,100 | 2036 | $ | 43,000 | $ | (43,000 | ) | $ | (4,200 | ) | $ | - | |||||||||||
| July 31, 2017 | $ | 307,100 | 2037 | $ | 46,000 | $ | (46,000 | ) | $ | (3,000 | ) | $ | - | |||||||||||
| January 31, 2018 | $ | 321,100 | 2038 | $ | 48,200 | $ | (48,200 | ) | $ | (2,200 | ) | $ | - | |||||||||||
| 2018 | 2017 | ||
| Income tax benefit at statutory rate | (21%) | (21%) | |
| Deferred income tax valuation allowance | 21% | 21% | |
| Reported tax rate | 0% | 0% |
NOTE 5. COMMITMENTS AND CONTINGENCIES
There are limitations on the utilization of net operating loss carryforwards, including a requirement that losses be offset against future taxable income, if any. In addition, there are limitations imposed by certain transactions which are deemed to be ownership changes. Accordingly, a valuation allowance has been established for the entire deferred tax asset.
NOTE 6. SEGMENT INFORMATION
Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. We identify our operating segments based on how our chief operating decision maker internally evaluates separate financial information, business activities and management responsibility.
The Company is authorizedused to issue 5,000,000 sharesoperate in two reportable segments: hospitality (hotel and travel agency) and early childhood education industry in China in the past years. Due to the disposal of preferred stock with a par value of $0.001 per share. No shares of preferred stockoperating subsidiaries on August 1, 2022, we currently have been issued or outstanding since Inception (April 2, 2008).
NOTE 7. SUBSEQUENT EVENTS
In accordance with ASC 855, "Subsequent Events"“Subsequent Events”, the Company has evaluated subsequent events through the date of issuance of these unaudited financial statements and has determined that it did not have any material recognizable subsequent events were noted.
On February 23, 2024, the Company borrowed $85,000 from its major stockholder, Mr. Lianyue Song., in the form of a demand note at 5% per annum.
On March 1, 2024, the Company returned $70,000, a portion of the notes payable to report.the related party, Hartford Hotel Investment Inc.
In the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB 8.11 million (about USD1.13 million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB 7.70 million (about USD1.07 million) to the supplier.
| 11 |
Forward-Looking Statements
This Form 10-Q contains or incorporates by reference “forward-looking statements,” as that term is used in federal securities laws, about our financial condition, results of operations and business. These statements include, among others:
| - | statements concerning the benefits that we expect will result from our business activities and results of business development that we contemplate or have completed, such as increased revenues; and statements of our expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this document or may be incorporated by reference to other documents that we will file with the SEC. You can find many of these statements by looking for words such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions used in this report or incorporated by reference in this report. |
These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied in those statements. Because the statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied. We caution you not to put undue reliance on these statements, which speak only as of the date of this report. Further, the information contained in this document or incorporated herein by reference is a statement of our present intention and is based on present facts and assumptions, and may change at any time and without notice, based on changes in such facts or assumptions.
Item 2. Management'sManagement’s Discussion and Analysis or Plan of Operation Overview
This discussion updates our business plan for the Six month periodsix-month periods ending January 31, 2018.2024. It also analyzes our financial condition at January 31, 2018,2024 and compares it to our financial condition at July 31, 2017.2023. This discussion and analysis should be read in conjunction with our audited financial statements for the year ended July 31, 2017,2023, including footnotes, contained in our Annual Report on Form 10-K, and with the unaudited financial statements for the interim period ended January 31, 2018,2024, including footnotes, which are included in this quarterly report.
Overview
Hartford Great Health Corp. was originally incorporated in the State of Nevada on April 2, 2008, ("Inception"). Since Inception,under the name PhotoAmigo, Inc. It changed its name to Hartford Great Health Corp. on August 22, 2018, and since then we have been engaged in activities to formulate and implement our business plan which is to develop photographic sharing and networking through its website PhotoAmigo.com
Ability to continue as a "going“going concern
The independent registered public accounting firm'sfirms’ reports on our financial statements as of July 31, 2017 and July 31, 20162023, includes a "going concern"“going concern” explanatory paragraph that describes substantial doubt about the Company'sCompany’s ability to continue as a going concern. Management'sManagement’s plans in regard to the factors prompting the explanatory paragraph are discussed in the financial statements, including footnotes thereto.
Plan of Operation
As of January 31, 2024, the company has issued a total of 100,108,000 shares of common stock. On December 11, 2018, 96,090,000 shares of common stock were issued at the price of $0.02 per share to raise an additional $1,921,800 in capital. On November 24, 2020, the Company issued additional 1,000,000 shares of common stock to a significant shareholder of the Company at $0.02 per share.
On December 28, 2018, the Company acquired Hangzhou Hartford Comprehensive Health Management, Ltd (“HZHF”). On March 22, 2019, the Company acquired 60 percent of Hangzhou Longjing Qiao Fu Vacation Hotel Co., Ltd. (“HZLJ”). On March 20, 2019, the Company acquired Shanghai Hartford Comprehensive Health Management, Ltd. (“HFSH”). Since 2019, HFSH had acquired and formed multiple subsidiaries and tried to develop the childhood education and childcare business. Impacted by Covid-19 pandemic and the government regulation implemented in education industry and the restrictions posted by the Chinese government to control the pandemic in China since 2021, to avoid further operation losses, on August 1, 2022, HFSH entered a contract with a related party, Shanghai Oversea Chinese Culture Media Ltd. (“SH Oversea”), to sell its subsidiaries for $900 (RMB 5,850). On August 1, 2022, HFUS entered a contract with SH Oversea and another individual, to sell HZHF and its subsidiaries for $1,000 (RMB 6,500).
The company’s sole subsidiary, HFSH was working with herbal manufacturers to develop new herbal health supplement products for wholesale distribution in China. Due to deflation in China, demand of herbal health supplement was lower than expected. Therefore, HFSH decided to deviate from its prior business focus and to engage in social media advertising endeavors. On January 10, 2024, HFSH changed its legal name from Shanghai Hartford Health Management, Ltd. to Hartford ZY Culture Media (Shanghai) Co., Ltd., hereon refer to as “HFZY”. and started to deliver media and advertisement services. The pent-up demand from social media influencers’ marketing needs on social media apps lead HFZY to seize the opportunity in providing advertisement services. HFZY begins to engage in social media advertising business on mainstream social media platforms such as Tik Tok, Toutiao, Kwai, RED, WeChat, and more. As an advertising partner of China’s major social media platforms, it provides customers with vertical integration services from early-stage advertising video creativity, photograph shooting, editing, to advertising operation and management on social media apps. HFZY is one of the total solution advertising providers for domestic social media industry in China.
Based on the current social media advertising business, HFZY will gradually launch overseas TikTok advertising campaign in 2024, providing social media advertising solutions for domestic Chinese customers to engage in international markets in the United States.
Subsequently in the month of February 2024, HFZY has entered advertising service contracts with ten customers and received approximately RMB 8.11 million (USD1.13 million) as advanced payment from these customers. HFZY also entered a major supplier contract for advertising placement and prepaid RMB 7.70 million (USD1.07 million). The Company expects the number of customers to grow and the advertising service revenue will significantly increase in the next few months due to the vast demand in social media advertising services.
| 12 |
Results of Operations – Three months ended January 31, 2024 Compared to Three months ended January 31, 2023.
Revenue: We recognized $62,443 and $nil revenue in the three months ended January 31, 2024 and 2023, respectively. For the three months ended January 31, 2024, the revenue was primarily generated from designing, making and placing video advertising for Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives. As both early childhood education services and hospitality services have been sold on August 1 2022, there was no revenue recognized for the three months ended January 31, 2023.
Operating Cost and Expenses: Cost of revenue increased to $55,505 for the three months ended January 31, 2024, compared to $nil during the comparable period of 2023. The increase of Cost of revenue was mainly due to the increase of the revenue. During the three months ended January 31, 2024, the selling, general and administrative expenses slightly increased to $21,942 compared to $21,362 during the comparable period of 2023.
Other Income (Expense): Other expense, net amount of $4,993 for the three months ended January 31, 2024, compared to $4,089 for the three months ended January 31, 2023. Other expenses for both periods were mainly resulted from interest expenses.
Net Income (Loss): We recorded a net loss of $19,997 or $(0.00) per share for the three months ended January 31, 2024, compared to a net loss of $25,451 or $(0.00) for the three months ended January 31, 2023, due to the factors discussed above.
Results of Operations – Six months ended January 31, 2024 Compared to Six months ended January 31, 2023.
Revenue: We recognized $62,443 and $nil revenue in the six months ended January 31, 2024 and 2023, respectively. For the six months ended January 31, 2024, the revenue was primarily generated from designing, making and placing video advertising for Shanghai DuBian Assets Management Ltd., which is managed by our major shareholder’s relatives. As both early childhood education services and hospitality services have been sold on August 1 2022, there was no revenue recognized for the six months ended January 31, 2023.
Operating Cost and Expenses: Cost of revenue increased to $55,505 for the six months ended January 31, 2024, compared to $nil during the comparable period of 2023. The increase of Cost of revenue was mainly due to the increase of the revenue. During the six months ended January 31, 2024, the selling, general and administrative expenses decreased to $42,134 compared to $76,010 during the comparable period of 2023. The decrease was due to the reduction of professional expenses occurred in US as a result of the downsize of business operation.
Other Income (Expense): Other expense, net amount of $10,257 for the six months ended January 31, 2024, compared to Other income, net amount of $530,961 for the corresponding period of 2023. Other expense for the six months ended January 31, 2024 was mainly resulted from interest expenses. Other income for the six months ended January 31, 2023, was mainly resulted from the gain on disposal of subsidiaries offset by interest expenses.
Net Income (Loss): We recorded a net loss of $45,453 or $(0.00) per share for the six months ended January 31, 2024, compared to a net income of $454,951 or $0.00 per share for the six months ended January 31, 2023, due to the factors discussed above.
Liquidity and Capital Resources
As of January 31, 2024, we had a working capital deficit of $(35,030),$4,562,442 comprised of $1,117 in cashcurrent assets of $9,730 and $36,147current liabilities of current liabilities.This$4,572,172. This represents a decreaseincrease of $72,006 in the working capital of $13,350deficit from the working capital deficit balance of $(21,680) reported as of July 31, 2017 which comprised cash2023 amount of $1,928$4,490,436.
We believe that our funding requirements for the next twelve months will be in excess of $800,000. We are currently seeking for further funding through related parties’ loan and current liabilities, comprising current liabilitiesfinance.
As of $23,608.
We maywill seek additional financing in the form of debt or equity. There is no assurance that we will be able to obtain any needed financing on favorable terms, or at all, or that we will find qualified purchasers for the sale of our stock. Any sales of our securities would dilute the ownership of our existing investors.
| 13 |
Cash Flows – Three Months Ended January 31, 2018 Compared to the Three Months Ended January 31, 2017.
Operating Activities
Cash used in operating expenses are incurred in connection with activities to meet current reporting requirements for a public company and there was no material change in the nature or extent of those activities.
During the six months ended January 31, 20182023, we used $13,474 in operatingrecorded net income of $454,951, adjusted by subsidiary disposal gain of $539,230, related party payables net with receivables increased by $26,955 and offset by other current payable decreased by $6,631.
Investing activities compared to the $8,841 used in the operations
Nil of investing activities occurred during the six months ended January 31, 2017. During2024 and 2023, respectively.
Financing activities
Cash provided by financing activities was $36,971 for the six months ended January 31, 2018, we recorded losses2024 as compared to $60,000 cash provided by financing activities for six months ended January 31, 2023. The cash flows provided by financing activities for both of $13,820, incurred non cash depreciation of $470 and accounts payable decreased by $381. Additionally the increase in interest payable of $257 is from accrued rather than paid interest and is a non-cash using item. By comparison, during the six months ended January 31, 2017, we recorded losses2024 and 2023, were primarily from the proceeds of $9,412, incurred non-cash depreciationnotes payable. The notes payable was borrowed from one related party with 5% annual interest rate. See Note 4 Related Party Transactions.
Future Capital Expenditures
We are currently engaging a consulting firm to evaluate and facilitate the potential uplisting of $470,the Company’s stock from the OTC market to the Nasdaq exchange. If all conditions align favorably, the Company intends to secure financing through either debt or equity. The funds raised will be allocated to cover the expenses associated with the uplisting process.
| 14 |
Off-Balance Sheet Arrangements
As of and accounts payable increased by $42 while accrued interest increased by $59.
Contractual Commitments
As of January 31, 20172024, we did not purchase any capital assets, we neither used, nor generated funds from investing activities.
Critical Accounting Policies
There have been no other changes in our critical accounting policies since our most recent audit dated July 31, 2017.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
As a "smaller“smaller reporting company"company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
An evaluation was performed under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this AnnualQuarterly Report. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that, as of January 31, 2018,2024, our disclosure controls and procedures were not effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC'sSEC’s rules and forms due to material weaknesses in our internal controls described below.
Management’s Report on Internal Control over Financial Reporting
Management’s assessment identified several material weaknesses in our internal controls over financial reporting that occurred during our last quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. These material weaknesses include the following:
| ● | Lack of proper authorization and approval procedures on significant business transactions. | |
| ● | Lack of competence accounting personnel at entity level and proper segregation of duties implemented. |
Changes in Internal Control
During the six months ended January 31, 2024, there has been no change in internal control within the Company.
| 15 |
PART II – OTHER INFORMATION
Item 1. Legal Proceedings.
We were not subject to any other legal proceedings during the six month periodsmonths ended January 31, 2018 or 20172024, and are not currently subject to any legal proceedings, and to the best of our knowledge, no such proceeding is threatened, the results of which would have a material impact on our results of operation or financial condition. Nor, to the best of our knowledge, are any of our officers or directors involved in any legal proceedings in which we are pending or threatened.
Item 1A. Risk Factors.
As a "smaller“smaller reporting company"company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None
Item 3. Defaults Upon Senior Securities.
None
Item 4. Mine Safety Disclosures
Not applicable to our Company.
Item 5. Other Information.
Not applicable to our Company.
Item 6. Exhibits.
The following exhibits are filed with or incorporated by referenced in this report:
101 Interactive Data Files
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Document
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
| 16 |
SIGNATURES
In accordance with Section 13 or 15(d) of the Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| HARTFORD GREAT HEALTH CORP. | ||||
| Date: March 14, 2024 | By: | /s/ ROSE HONG WANG | ||
| Rose Hong Wang | ||||
| Chief Executive Officer | ||||
| 17 | ||||